Dl-3-n-butylphthalide and Cerebrolysin Treatment in Acute Ischemic Stroke

Clinical trial NCT02149875 · COMPLETED

Trial details

NCT number: NCT02149875
Sponsor: Shanghai 6th People's Hospital
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Cerebral Stroke Within 12 Hours for the First Time

Start date: 2010-01-01
Primary completion: 2010-05-01
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.